CATALENT PHARMA: Faces 24 Civil Suits for Amnesteem(R) Injuries

Catalent Pharma Solutions, Inc. faces 24 civil lawsuits filed by a variety of plaintiffs purportedly injured by their use of the prescription acne medication Amnesteem(R), a generic form of isotretinoin.

Beginning in November 2006, the Company, along with several pharmaceutical…

CATALENT PHARMA: To Respond to FDA Warning Letter Over Facility

Catalent Pharma Solutions, Inc. intends to cooperate with the U.S. Food and Drug Administration in response to the Warning Letter concerning the Company’s North Raleigh Sterile Technologies facility.

In the second quarter of fiscal 2008, the FDA initiated an inspection, or…